Avantis International Small Cap Equity ETF - AVDS STOCK NEWS

Welcome to our dedicated page for Avantis International Small Cap Equity ETF news (Ticker: AVDS), a resource for investors and traders seeking the latest updates and insights on Avantis International Small Cap Equity ETF stock.

Avantis International Small Cap Equity ETF (AVDS) is a recently launched exchange traded fund by Avantis Investors®, a $27 billion investment branch of American Century Investments® known for providing well-diversified investment solutions. Listed on NYSE Arca, Inc., AVDS aims for long-term capital appreciation by investing primarily in a diverse group of non-U.S. small cap companies across various market sectors, industry groups, and countries.

The fund is actively managed by a team comprising Avantis Chief Investment Officer Eduardo Repetto, Senior Portfolio Managers Mitchell Firestein, Daniel Ong, CFA, Ted Randall, and Portfolio Manager Matthew Dubin. The ETF seeks to enhance emphasis on profitability and value characteristics, selectively including securities expected to yield higher returns while underweighting or excluding those with lower expected returns. AVDS boasts a gross expense ratio of 0.30%.

The launch of AVDS complements Avantis’ existing U.S. Small Cap Equity ETF (AVSC) by applying similar investment principles to international markets. The addition of AVDS further extends Avantis' growing ETF lineup, which includes recent launches such as the Avantis All Equity Markets Value ETF (AVGV), Avantis All International Markets Equity ETF (AVNM), Avantis All International Markets Value ETF (AVNV), and Avantis Moderate Allocation ETF (AVMA). These funds are multi-region and multi-asset class solutions designed to help clients achieve their investment goals with added value and consistency.

American Century Investments, the parent company of Avantis Investors, is a globally recognized asset manager founded in 1958. With offices in major financial hubs like New York, London, and Hong Kong, the company serves a diverse client base, from financial professionals and institutions to individual investors. Notably, American Century Investments supports breakthrough medical research through the Stowers Institute for Medical Research, which owns over 40% of the company and has received nearly $2 billion in dividends since 2000.

Investing in AVDS involves risks such as political instability and currency fluctuations, especially in emerging markets. Additionally, small-cap stocks have historically been more volatile than those of larger companies, often having limited resources, product lines, and market access. Investors are advised to consider these factors alongside the fund’s investment objectives, risks, and expenses as detailed in its prospectus.